Guillain-Barré syndrome in a 93-year-old woman: rapid improvement of neurologic function following intravenous immunoglobulin

P A Uldry; J Bogousslavsky; F Regli

Guillain-Barré syndrome in a 93-year-old woman: rapid improvement of neurologic function following intravenous immunoglobulin

Schweiz Arch Neurol Psychiatr (1985). 1991;142(4):301-5.

Authors

P A Uldry¹, J Bogousslavsky, F Regli

Affiliation

¹ Department of Neurology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

PMID: 1719624

Abstract

We treated a 93-year-old woman with Guillain-Barré syndrome (GBS) with high-dose intravenous immunoglobulin (IgIV). The patient improved within 48 hours of the onset of treatment. There were no adverse side effects.

Publication types

Case Reports

MeSH terms

Aged
Aged, 80 and over
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Humans
Immunoglobulin G / cerebrospinal fluid
Immunoglobulins, Intravenous / administration & dosage*
Infusions, Intravenous
Neurologic Examination*
Polyradiculoneuropathy / immunology
Polyradiculoneuropathy / therapy*

Substances

Immunoglobulin G
Immunoglobulins, Intravenous